Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.05 par value
-
Shares outstanding
-
2K
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
11.8M
-
Shares change
-
-62.6K
-
Total reported value, excl. options
-
$361M
-
Value change
-
-$13.4M
-
Put/Call ratio
-
0.57
-
Number of buys
-
59
-
Number of sells
-
-69
-
Price
-
$30.53
Significant Holders of SURMODICS INC - Common Stock, $0.05 par value (SRDX) as of Q1 2025
162 filings reported holding SRDX - SURMODICS INC - Common Stock, $0.05 par value as of Q1 2025.
SURMODICS INC - Common Stock, $0.05 par value (SRDX) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (1.16M shares), ALLIANCEBERNSTEIN L.P. (849K shares), VANGUARD GROUP INC (799K shares), Soleus Capital Management, L.P. (789K shares), MORGAN STANLEY (676K shares), Hudson Bay Capital Management LP (465K shares), GABELLI FUNDS LLC (396K shares), Qube Research & Technologies Ltd (389K shares), STATE STREET CORP (362K shares), and DIMENSIONAL FUND ADVISORS LP (352K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.